Odomzo Capsule
Product Images NDC 47335-303

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Odomzo (NDC 47335-303). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Chemical Structure Of Sonidegib (Odomzo 01)

Chemical structure of sonidegib shown as a line drawing with labeled functional groups, highlighting its molecular framework including aromatic rings, heterocycles, and substituents, along with the associated diphosphate salt form (2 H3PO4).*

FDA Label Image

Principal Display Panelndc 0078-0645-15odomzo(sonidegib) Capsules200 mgpharmacist: Dispense With Medication Guide.30 Capsulesrx Only (Odomzo 02)

Odomzo (sonidegib) 200 mg oral capsules label with NDC 47335-303-83. The label shows the product strength (200 mg), dosage form (capsules), and package size of 30 capsules. It includes directions to dispense with a medication guide. The labeler is Sun Pharmaceutical Industries, Inc., and it lists storage and handling instructions along with manufacturer and distributor details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.